An Anti-cancer Drug in Short Supply Can Now be Made by Microbes

The supply of a plant-derived anti-cancer drug can finally meet global demand after a team of scientists from Denmark and the U.S. engineered yeast to produce the precursor molecules. Previously, obtaining one gram of the chemotherapy drug required growing and harvesting 500 kilograms of the native plant's leaves.


Click to view original post